Surgical sutures of unsymmetrically substituted 1,4-dioxane-2,5-diones

• US 3,960,152 A
• Filed: 03/14/1975
• Issued: 06/01/1976
• Est. Priority Date: 01/21/1974
• Status: Expired due to Term

• Current Assignee: American Cyanamid Co (Pfizer Inc.)
• Original Assignee: American Cyanamid Co (Pfizer Inc.)
• Inventors: Perciaccante, Vincent Anthony, Rosensaft, Michael Norman, Augurt, Thomas Anthony
• Primary Examiner(s): Trapp, Lawrence W.
• Application Number:
  US05/558,529
• Time in Patent Office: 445 Days
• Field of Search: 128/335, 128/335.5, 128/DIG. 8, 206/63.3, 3/1
• US Class Current: 606/230
• CPC Class Codes: A61L 17/105 Polyesters not covered by A61L17/12
• CPC Class Codes: C08G 63/08 Lactones or lactides

Abstract

Unsymmetrically 3,6-substituted 1,4-dioxane-2,5-diones may be polymerized to give living-tissue absorbable, hydrolytically degradable surgically useful polymers. These polymers have predominantly regular rather than random spacings of side chains, may be stereoregular and tend toward higher crystallinity than randomly sequenced polymers. A polymer of 3-methyl-1,4-dioxane-2,5-dione has the same empirical formula as an equimolecular copolymer of lactic and glycolic acid but has unique physical properties resulting from its more regular steric configuration. Polymers and copolymers of 3- and 3,6-unsymmetrically substituted 1,4-dioxane-2,5-diones have surgically useful mechanical properties. On implantation, in living mammalian tissue, the polymers are absorbed, and replaced by living tissue.

Claims

1. A method of closing a wound of living tissue which comprises:

sewing the edges of the wound with a surgical suture consisting of at least one filament of polymer containing more than 2% by weight of recurring units of the formula;

##EQU18## and the remaining units are ##EQU19## and ##EQU20## wherein R₁ and R₂ are not the same as R₃ and R₄, R₁ has at least one carbon atom, and R₁, R₂, R₃, R₄, R₅, R₆, R₇ and R₈ are separately selected from the group consisting of hydrogen, and the radicals methyl, ethyl, propyl, isopropyl, butyl, isobutyl, cyclohexyl, and phenyl,

embedding the suture in living tissue and

leaving the suture in said tissue until said suture is absorbed by the tissue during the healing process.

2. The method of claim 1 in which the polymer has the formula:

##EQU21## where n is such that the weight average molecular weight is at least about 5,000.

3. The method of claim 1 in which the polymer contains more than 2 mole % of recurring units of the formula:

##EQU22## the remaining units being ##EQU23## where R₁ is CH₃ -- or H --.

4. A method of retaining living tissue in a desired location and relationship during a healing process which comprises:

positioning and emplacing living tissue with a surgical element of polymer containing more than 2% by weight of recurring units of the formula;

##EQU24## and the remaining units are ##EQU25## and ##EQU26## where R₁ and R₂ are not the same as R₃ and R₄, R₁ has at least one carbon atom, and R₁, R₂, R₃, R₄, R₅, R₆, R₇ and R₈ are separately selected from the group consisting of hydrogen, and the radicals methyl, ethyl, propyl, isopropyl, butyl, isobutyl, cyclohexyl, and phenyl,

6. The method of claim 4 in which the polymer has the formula:

##EQU27## where n is such that the weight average molecular weight is at least about 5,000.

7. The method of claim 4 in which the polymer contains more than 2 mole % of recurring units of the formula:

##EQU28## the remaining being ##EQU29## where R₁ is CH₃ -- or H --.

5. embedding said element in living tissue and

leaving said element in said tissue until said element is absorbed by the tissue during the healing process, the element retaining a high proportion of its original strength for at least three days and being substantially absorbed in about six months when the living tissue is muscular tissue, and a proportionate time in other tissues.